Search Orphan Drug Designations and Approvals
-
Generic Name: | isavuconazonium sulfate |
---|---|
Date Designated: | 10/20/2014 |
Orphan Designation: | Treatment of invasive candidiasis/candidemia |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Astellas Pharma Global Development, Inc. 1 Astellas Way Northbrook, Illinois 60062 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-